Eli Lilly Seeks Emergency Authorization For Covid-19 Drug, May Produce 100,000 Doses By Month-EndForbes • 10/07/20
Eli Lilly Requests Emergency Use Authorization for COVID-19 Treatment CandidateThe Motley Fool • 10/07/20
Eli Lilly Files Emergency Use Authorization Request For A Covid-19 TherapyInvestors Business Daily • 10/07/20
Lilly submits authorization request to FDA for antibody-based COVID-19 therapyMarket Watch • 10/07/20
The FDA Just Ranked Coronavirus Tests by Sensitivity. Here's What That MeansThe Motley Fool • 10/03/20
Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - October 01, 2020Zacks Investment Research • 10/01/20
Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 09/29/20
Trulicity® (dulaglutide) is now indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who have multiple cardiovascular risk factors or established cardiovascuGlobeNewsWire • 09/22/20
Eli Lilly Reports MonarchE Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 09/22/20
Eli Lilly CEO: Speed and industry cooperation are aiding coronavirus treatment developmentCNBC • 09/22/20
Pharma ETFs to Benefit from Lilly's Coronavirus Antibody ProgressZacks Investment Research • 09/21/20
Verzenio® Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast CancerPRNewsWire • 09/20/20
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 TrialGlobeNewsWire • 09/17/20
Eli Lilly and Company (LLY) Management Presents at Cantor Fitzgerald Healthcare Conference (Transcript)Seeking Alpha • 09/17/20